-
481
Triterpenoids from Chios Mastiha Resin Against MASLD—A Molecular Docking Survey
Published 2025-01-01Subjects: “…non-alcoholic liver disease…”
Get full text
Article -
482
Dose-response relationship between the fatty liver index and asthma risk: NHANES 2001~2018
Published 2025-02-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
483
Gut Microbiota and its Metabolites in Pathogenesis of NAFLD
Published 2023-02-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
484
Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlled multicenter post-registration (phase IV) clinical trial «Jaguar» (PHG-M2/P03-12)
Published 2018-08-01Get full text
Article -
485
Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
Published 2021-01-01Subjects: “…metabolic associated fatty liver disease…”
Get full text
Article -
486
Modulatory effects of Lactiplantibacillus plantarum on chronic metabolic diseases
Published 2023-07-01Subjects: “…Non-alcoholic fatty liver disease…”
Get full text
Article -
487
Nonlinear relationship between hepatic steatosis index and reversion to normal glucose regulation in Chinese adults with prediabetes
Published 2025-02-01Subjects: “…Metabolic associated fatty liver disease…”
Get full text
Article -
488
Liver transplantation for homozygous familial hypercholesterolemia: a retrospective analysis from Chinese experience
Published 2025-01-01Subjects: Get full text
Article -
489
Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization study
Published 2025-01-01Subjects: “…nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
490
Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro
Published 2025-01-01Subjects: “…metabolic associated fatty liver disease…”
Get full text
Article -
491
The Role of the Liver in the Pathophysiology of PCOS: A Literature Review
Published 2025-01-01Subjects: “…nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
492
Association of daily step counts and step intensity with mortality among US adults: a cross–sectional study of NHANES 2005–2006
Published 2025-01-01Subjects: “…Metabolic dysfunction–associated steatotic liver disease…”
Get full text
Article -
493
FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
Published 2024-12-01Subjects: “…non-alcoholic fatty liver disease (nafld)…”
Get full text
Article -
494
Development and validation of machine learning models for MASLD: based on multiple potential screening indicators
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
495
Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis
Published 2025-02-01Subjects: “…non-alcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
496
Age-Dependent Effects of Butyl Benzyl Phthalate Exposure on Lipid Metabolism and Hepatic Fibrosis in Mice
Published 2025-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
497
Helicobacter pylori Infection and Hepatobiliary Pathology
Published 2018-09-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
498
Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
Published 2021-04-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
499
-
500
The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article